Expert Blog | Beta Cells in Diabetes

Expert BlogBlog RSS

About the Blog

This forum allows a wide variety of leading researchers, endocrinologists, and primary care providers to expand informally on emerging research, case studies, and resources related to beta cells in diabetes, as well providing an opportunity for you to discuss and debate these issues.

Posts by Topic

Posts by Author

Sonal Singh, MD, MPH
General Internist

Assistant Professor of Medicine, Division of General Internal Medicine
Johns Hopkins University School of Medicine;
Joint Appointment in International Health, Center for Public Health and Human Rights
Johns Hopkins Bloomberg School of Public Health

Read the full biography

Tailoring Clinical Practice Guidelines for Patients with Type 2 Diabetes
Posted September 21, 2011 by Sonal Singh, MD, MPH

Tags: DPP-4 inhibitors, metformin, sulfonylureas (SUs), thiazolidinediones (TZDs)

Several guidelines emphasize the need to use existing therapeutic options to help patients and providers achieve various treatment goals, including target glycated hemoglobin levels to improve microvascular outcomes among patients with type 2 diabetes.
- Continue Reading
- 1 Comment
Balancing Benefit And Risk In T2DM: Beyond The Beta Cell
Posted March 8, 2011 by Sonal Singh, MD, MPH

Tags: GLP-1 agonists, glycemic control, thiazolidinediones (TZDs)

Type 2 diabetes (T2D) is a progressive multisystem heterogeneous disease. Apart from its well known microvascular and ischemic macrovascular complications, recent evidence has accumulated that patients with this disease are also at an increased risk of congestive heart failure, fractures, cancer, pancreatitis, and serious infections such as pneumonia.
- Continue Reading
- 0 Comments

Betacell

A resource for physicians established by the Endocrine Society

Text Size:

Expert BlogBlog RSS

About the Blog

Posts by Topic

Posts by Author

Tailoring Clinical Practice Guidelines for Patients with Type 2 Diabetes

Balancing Benefit And Risk In T2DM: Beyond The Beta Cell